| RS2531002170 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531002366 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531002584 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation 1, Capillary malformation-arteriovenous malformation 1 |
| RS2531003190 |
RASA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Capillary malformation-arteriovenous malformation syndrome, Cardiovascular phenotype |
| RS2531003311 |
FBXO11
|
Health Risk |
Likely pathogenic |
FBXO11-related disorder, FBXO11-related disorder |
| RS2531003398 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531003517 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531003554 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531003684 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531003739 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531003767 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2531003780 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531003856 |
RASA1
|
Health Risk |
Likely pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531003866 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531003868 |
RASA1
|
Health Risk |
Pathogenic |
Capillary malformation-arteriovenous malformation syndrome, Capillary malformation-arteriovenous malformation syndrome |
| RS2531004004 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531010723 |
PIK3R1
|
Health Risk |
Pathogenic |
Agammaglobulinemia 7, autosomal recessive |
| RS2531011660 |
PIK3R1
|
Health Risk |
Likely pathogenic |
SHORT syndrome, SHORT syndrome |
| RS2531013627 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531013834 |
LIFR
|
Health Risk |
Pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS2531022178 |
FAT4
|
Health Risk |
Pathogenic |
— |
| RS2531028269 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531028773 |
ATP2C1
|
Health Risk |
Likely pathogenic |
— |
| RS2531028797 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531028879 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531029612 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2531030542 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2531035426 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531035684 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531038212 |
COL7A1
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa dystrophica, Recessive dystrophic epidermolysis bullosa |
| RS2531043713 |
LIFR
|
Health Risk |
Likely pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS2531043843 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531044217 |
LIFR
|
Health Risk |
Pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS2531044671 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531047469 |
COL7A1
|
Health Risk |
Likely pathogenic |
COL7A1-related disorder, COL7A1-related disorder |
| RS2531047714 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531047728 |
LIFR
|
Health Risk |
Likely pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS2531051260 |
ATP2C1
|
Health Risk |
Pathogenic |
— |
| RS2531053190 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531054735 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2531055112 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531055149 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531057032 |
FBXO11
|
Health Risk |
Likely pathogenic |
Developmental disorder, Developmental disorder |
| RS2531057878 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531059728 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531059791 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531062985 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531063518 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531063636 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2531066176 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2531070418 |
ANKRD17
|
Health Risk |
Pathogenic |
— |
| RS2531070828 |
ANKRD17
|
Health Risk |
Likely pathogenic |
Chopra-Amiel-Gordon syndrome, Chopra-Amiel-Gordon syndrome |
| RS2531071168 |
LIFR
|
Health Risk |
Pathogenic |
Stuve-Wiedemann syndrome, Stuve-Wiedemann syndrome |
| RS2531071182 |
LIFR
|
Health Risk |
Pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS2531071794 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531076655 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2531076892 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2531076982 |
AP3B1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2531080753 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2531081710 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531082087 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531082528 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531087867 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531088120 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531091833 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2531099938 |
ADAM17
|
Health Risk |
Pathogenic/Likely pathogenic |
Inflammatory skin and bowel disease, neonatal |
| RS2531100944 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2531101531 |
FBXO11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS2531101705 |
FBXO11
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2531103719 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531105647 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531106124 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
7 conditions, 7 conditions |
| RS2531106977 |
OCLN
|
Health Risk |
Pathogenic |
— |
| RS2531107840 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2531108645 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531110975 |
AP3B1
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 2, Hermansky-Pudlak syndrome 2 |
| RS2531113923 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
7 conditions, 7 conditions |
| RS2531113955 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS2531114400 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531114421 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531115922 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2531116066 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531116819 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531117312 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2531119855 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS2531121295 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531123144 |
OCLN
|
Health Risk |
Likely pathogenic |
Pseudo-TORCH syndrome 1, Pseudo-TORCH syndrome 1 |
| RS2531123654 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531123732 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531124019 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS2531130676 |
LIFR
|
Health Risk |
Pathogenic/Likely pathogenic |
Stüve-Wiedemann syndrome 1, Stüve-Wiedemann syndrome 1 |
| RS2531130694 |
LIFR
|
Health Risk |
Pathogenic |
— |
| RS2531131693 |
LIFR
|
Health Risk |
Likely pathogenic |
— |
| RS2531132403 |
ATP2C1
|
Health Risk |
Pathogenic |
— |
| RS2531133278 |
ATP2C1
|
Health Risk |
Pathogenic |
— |
| RS2531133399 |
ATP2C1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial benign pemphigus, Familial benign pemphigus |
| RS2531134507 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
7 conditions, 7 conditions |
| RS2531143837 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS2531143895 |
COL7A1
|
Health Risk |
Pathogenic |
— |
| RS2531144033 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |